EDT talks about new OSD contracting biz

By Gareth Macdonald and Claire Videau

- Last updated on GMT

US-based Elan Drug Technologies (EDT) says new oral solid dose (OSD) contract manufacturing offering will add value to business.

in-Pharmatechnologist spoke with James Botkin, EDT’s SVP of operations, who explained that the new offering, launched last month​, is based on the manufacturing capacity and capabilities the firm has developed over the last forty years.

Botkin also said that the competitiveness of the new unit, which will focus on the production and development of oral solid dose drugs, is reliant on operating efficiencies established by its core drug delivery business.

He also suggested that, if successful, the OSD service will make EDT a more valuable proposition, which may make it more attractive to potential buyers if parent firm Elan restarts​ efforts to split the unit from its BioNeurology business.

Related news

Show more

Related products

show more

Flexible Filling Solution for CMOs

Flexible Filling Solution for CMOs

Single Use Support GmBH | 18-May-2022 | Insight Guide

Achieving flexibility requires modularity of technologies.

CMOs and CDMOs aspire to be flexible for multiple applications. Efficient automated...

Eastern & Western Manufacturing Solutions

Eastern & Western Manufacturing Solutions

Piramal Pharma Solutions | 15-Mar-2022 | Technical / White Paper

The best manufacturing site for a product can change throughout the life cycle. When bringing new drugs to market, biopharma companies may benefit from...

Related suppliers

Follow us

Products

View more

Webinars